269 related articles for article (PubMed ID: 22858275)
1. Thromboembolic events before esophagectomy for esophageal cancer do not result in worse outcomes.
Teman NR; Silski L; Zhao L; Kober M; Urba SC; Orringer MB; Chang AC; Lin J; Reddy RM
Ann Thorac Surg; 2012 Oct; 94(4):1118-24; discussion 1124-5. PubMed ID: 22858275
[TBL] [Abstract][Full Text] [Related]
2. Thromboembolic events in patients with urothelial carcinoma undergoing neoadjuvant chemotherapy and radical cystectomy.
Zareba P; Patterson L; Pandya R; Margel D; Hotte SJ; Mukherjee SD; Elavathil L; Daya D; Shayegan B; Pinthus JH
Urol Oncol; 2014 Oct; 32(7):975-80. PubMed ID: 25027682
[TBL] [Abstract][Full Text] [Related]
3. Neoadjuvant chemoradiation versus chemotherapy for patients undergoing esophagectomy for esophageal cancer.
Luu TD; Gaur P; Force SD; Staley CA; Mansour KA; Miller JI; Miller DL
Ann Thorac Surg; 2008 Apr; 85(4):1217-23; discussion 1223-4. PubMed ID: 18355499
[TBL] [Abstract][Full Text] [Related]
4. Preoperative chemoradiotherapy prior to esophagectomy in elderly patients is not associated with increased morbidity.
Rice DC; Correa AM; Vaporciyan AA; Sodhi N; Smythe WR; Swisher SG; Walsh GL; Putnam JB; Komaki R; Ajani JA; Roth JA
Ann Thorac Surg; 2005 Feb; 79(2):391-7; discussionn 391-7. PubMed ID: 15680801
[TBL] [Abstract][Full Text] [Related]
5. Increased risk of thromboembolism in esophageal cancer patients treated with neoadjuvant chemoradiotherapy.
Bosch DJ; Van Dalfsen QA; Mul VE; Hospers GA; Plukker JT
Am J Surg; 2014 Aug; 208(2):215-21. PubMed ID: 24534559
[TBL] [Abstract][Full Text] [Related]
6. Effects of neoadjuvant therapy on perioperative morbidity in elderly patients undergoing esophagectomy for esophageal cancer.
Ruol A; Portale G; Castoro C; Merigliano S; Cagol M; Cavallin F; Chiarion Sileni V; Corti L; Rampado S; Costantini M; Ancona E
Ann Surg Oncol; 2007 Nov; 14(11):3243-50. PubMed ID: 17713823
[TBL] [Abstract][Full Text] [Related]
7. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
[TBL] [Abstract][Full Text] [Related]
8. Feasibility of thoracoscopic esophagectomy after neoadjuvant chemotherapy.
Tanaka E; Okabe H; Tsunoda S; Obama K; Kan T; Kadokawa Y; Akagami M; Sakai Y
Asian J Endosc Surg; 2012 Aug; 5(3):111-7. PubMed ID: 22776501
[TBL] [Abstract][Full Text] [Related]
9. Neoadjuvant chemoradiotherapy for locally advanced esophageal cancer: experience at a single institution.
Malaisrie SC; Untch B; Aranha GV; Mohideen N; Hantel A; Pickleman J
Arch Surg; 2004 May; 139(5):532-8; discussion 538-9. PubMed ID: 15136354
[TBL] [Abstract][Full Text] [Related]
10. Risk of thromboembolic events after perioperative chemotherapy versus surgery alone for esophageal adenocarcinoma.
Verhage RJ; van der Horst S; van der Sluis PC; Lolkema MP; van Hillegersberg R
Ann Surg Oncol; 2012 Feb; 19(2):684-92. PubMed ID: 21837523
[TBL] [Abstract][Full Text] [Related]
11. Induction therapy does not increase surgical morbidity after esophagectomy for cancer.
Lin FC; Durkin AE; Ferguson MK
Ann Thorac Surg; 2004 Nov; 78(5):1783-9. PubMed ID: 15511475
[TBL] [Abstract][Full Text] [Related]
12. Association of clinical and dosimetric factors with postoperative pulmonary complications in esophageal cancer patients receiving intensity-modulated radiation therapy and concurrent chemotherapy followed by thoracic esophagectomy.
Hsu FM; Lee YC; Lee JM; Hsu CH; Lin CC; Tsai YC; Wu JK; Cheng JC
Ann Surg Oncol; 2009 Jun; 16(6):1669-77. PubMed ID: 19267157
[TBL] [Abstract][Full Text] [Related]
13. Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm.
Pennathur A; Luketich JD; Landreneau RJ; Ward J; Christie NA; Gibson MK; Schuchert M; Cooper K; Land SR; Belani CP
Ann Thorac Surg; 2008 Jun; 85(6):1930-6; discussion 1936-7. PubMed ID: 18498797
[TBL] [Abstract][Full Text] [Related]
14. Multimodality treatment for esophageal cancer: the role of surgery and neoadjuvant therapy.
Makary MA; Kiernan PD; Sheridan MJ; Tonnesen G; Hetrick V; Vaughan B; Graling P; Elster E
Am Surg; 2003 Aug; 69(8):693-700; discussion 700-2. PubMed ID: 12953828
[TBL] [Abstract][Full Text] [Related]
15. Factors affecting postoperative course and survival after en bloc resection for esophageal carcinoma.
Mariette C; Taillier G; Van Seuningen I; Triboulet JP
Ann Thorac Surg; 2004 Oct; 78(4):1177-83. PubMed ID: 15464466
[TBL] [Abstract][Full Text] [Related]
16. Correlations between neoadjuvant treatment, anemia, and perioperative complications in patients undergoing esophagectomy for cancer.
Melis M; McLoughlin JM; Dean EM; Siegel EM; Weber JM; Shah N; Kelley ST; Karl RC
J Surg Res; 2009 May; 153(1):114-20. PubMed ID: 19201421
[TBL] [Abstract][Full Text] [Related]
17. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.
Liao Z; Zhang Z; Jin J; Ajani JA; Swisher SG; Stevens CW; Ho L; Smythe R; Vaporciyan AA; Putnam JB; Walsh GL; Roth JA; Yao JC; Allen PK; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1484-93. PubMed ID: 15590179
[TBL] [Abstract][Full Text] [Related]
18. [Chemoradiotherapy followed by surgery in treatment of locally advanced esophageal carcinoma: a phase II trial].
Fu JH; Rong TH; Li XD; Hu Y; Ou W; Hu YH; Li Q
Ai Zheng; 2004 Nov; 23(11 Suppl):1473-6. PubMed ID: 15566661
[TBL] [Abstract][Full Text] [Related]
19. Pathologic response after neoadjuvant therapy is the major determinant of survival in patients with esophageal cancer.
Meredith KL; Weber JM; Turaga KK; Siegel EM; McLoughlin J; Hoffe S; Marcovalerio M; Shah N; Kelley S; Karl R
Ann Surg Oncol; 2010 Apr; 17(4):1159-67. PubMed ID: 20140529
[TBL] [Abstract][Full Text] [Related]
20. Nodal metastasis from locally advanced esophageal cancer: how neoadjuvant therapy modifies their frequency and distribution.
Castoro C; Scarpa M; Cagol M; Ruol A; Cavallin F; Alfieri R; Zanchettin G; Rugge M; Ancona E
Ann Surg Oncol; 2011 Dec; 18(13):3743-54. PubMed ID: 21556952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
